Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1841 of 5804
-
New steroid test may spot hidden cause of high blood pressure without risky drug changes
Diagnosis Recruiting nowThis prospective, single-center observational study aims to evaluate whether a steroid-based screening method can more accurately identify Primary Aldosteronism (PA) in hypertensive patients who remain on their usual antihypertensive medications, compared with the conventional al…
Sponsor: Qifu Li • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New pill shows promise for social anxiety in early trial
Symptom relief CompletedThis Phase 2 study (protocol number EMP-01-201) will determine the safety and tolerability of a short-term treatment with an oral dosage form of EMP-01 in adult participants with social anxiety disorder (SAD) and will assess exploratory efficacy of repeated doses of EMP-01 versus…
Phase: PHASE2 • Sponsor: atai Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
AI model spots AFib recurrence risk after ablation
Knowledge-focused CompletedWe aimed to develop an dual-branch deep learning network that integrates feature representations extracted from medical texts using large language models, with structured data features derived from perioperative records of AF ablation patients. This integrated approach provides n…
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New hope for advanced cancer? first human trial of HS-20122 begins
Disease control Recruiting nowThis is a first-in-human (FIH) Phase I, multi-center, open-label, study of HS-20122, in patients with advanced solid tumors. This study will evaluate the safety, tolerability, pharmacokinetics and efficacy of HS-20122 in advanced solid tumors.
Phase: PHASE1 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
PRP and a daily pill: a new combo for ED?
Disease control CompletedPlatelet-rich plasma is being studied as a regenerative treatment option for erectile dysfunction, but it is unclear whether adding daily tadalafil gives additional benefit over platelet-rich plasma alone. This study evaluates adult men with mild to mild-moderate erectile dysfunc…
Phase: PHASE4 • Sponsor: Benha University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New ultrasound technique could sharpen heart arrhythmia diagnosis
Diagnosis ENROLLING_BY_INVITATIONAtrial and ventricular cardiac arrhythmias are serious public health problems in the United States, affecting over 5% of Americans and are major causes of stroke and heart failure leading to increased morbidity and mortality. This proposed clinical trial will determine how electr…
Phase: NA • Sponsor: Columbia University • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
Could one pill a day keep the transplant safe?
Disease control Recruiting nowWorld Health Organization considers non-adherence has a strong negative impact on the health of patients with chronic diseases. In transplantation, adherence to immunosuppressive drug regimens associates with late rejection and graft loss making it a critical determinant of patie…
Phase: PHASE4 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can community health workers help close the heart health gap in philadelphia?
Disease control Recruiting nowCardiovascular disease (CVD) disproportionately affects racial/ethnic minorities and underserved populations in Philadelphia. This study aims to evaluate the effectiveness of an enhanced community health worker (CHW) program that combines the evidence-based DECIDE self-management…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Live biopsy study aims to predict immunotherapy response in cancer patients
Knowledge-focused Recruiting nowThis study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up for suspected or confirmed cancer.
Sponsor: Elephas • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Propofol, ketamine, or both? major trial seeks safer emergency intubation
Disease control Recruiting nowThe best hypnotic choice to optimize the balance between good intubation condition quality and hemodynamic stability during RSI performed in the operating theatre remained to be investigated. Therefore, a randomized study evaluating the efficacy of propofol, ketamine, and a comb…
Phase: PHASE3 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug TALZENNA tested for Tough-to-Treat breast cancer
Disease control OngoingThe purpose of this study is to learn about the safety of TALZENNA for the patients with breast cancer that cannot be removed by surgery and has come back. These participants also have a past treatment with medicines that try to stop the growth of cancer cells. This study is see…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Exercise program aims to reverse Hospital-Related muscle loss in kidney patients
Disease control Recruiting nowThe aging Veteran population has more frequent inpatient hospitalization than non-Veterans. In addition, older Veterans have an inability to fully recover muscle mass and function after hospital-acquired weakness. The problem of hospital-acquired weakness is greatly increased in …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New cancer drug JMT108 enters human testing
Disease control Recruiting nowThis study is designed as an open-label, multi-center Phase 1 clinical study in participants with advanced malignant tumors to evaluate the safety, tolerability, PK characteristics, and preliminary anti-tumor activity of JMT108 injection, and to determine the RP2D/schedule for su…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can silkworm powder boost brain health in Alzheimer's?
Disease control Recruiting nowThe purpose of this clinical trial is to determine whether silkworm pupa powder is effective in treating Alzheimer's disease. It will also investigate whether silkworm pupa powder can improve the nutritional and frailty status of patients with Dementia. The main questions it aims…
Phase: NA • Sponsor: Zhejiang Provincial Tongde Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Text messages may curb binge drinking in young adults not in college
Disease control OngoingThis project aims to test the efficacy of a text message intervention, ASPIRE, designed to address cognitive and behavioral elements and modify exposure to peers that influence drinking behaviors. Young adults who are contemplating reducing their drinking will be recruited from a…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug APL-9796 tested for lung blood pressure disorder
Disease control Recruiting nowThe AP13CP02 study is a phase 2, open-label, dose escalation trial to determine how safe and tolerable multiple subcutaneous (SC) injections of APL-9796 are for patients with PH. The study will also assess how effective APL-9796 could be for treating patients with PH and whether …
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New ultrasound technique could unlock secrets of placental health in pregnancy
Knowledge-focused Recruiting nowPreeclampsia and intrauterine growth restriction (IUGR) are two principal complications of pregnancy. These diseases are related to placental dysfunction nevertheless knowledge of its pathophysiological mechanisms remains inadequate. No etiological treatment for these pathologie…
Phase: PHASE3 • Sponsor: Central Hospital, Nancy, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
DIY swab could revolutionize anal cancer screening for HIV patients
Prevention Recruiting nowComunity health actions are set up in populations of women aged 30 to 65 in vulnerable situations living in the outlying areas of Reunion Island. The idea is to evaluate those action on health
Phase: NA • Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
AI alert aims to curb opioid overdoses in real time
Knowledge-focused OngoingThis clinical trial aims to evaluate the pilot implementation of a machine-learning (ML)-driven clinical decision support (CDS) tool designed to predict opioid overdose risk within the electronic health record (EHR) system at UF Health Internal Medicine and Family Medicine clinic…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Can a daily supplement stop breast implant scarring?
Prevention OngoingThe study plans to evaluate capsular contracture at 1-year follow-up in postmastectomy patients receiving immediate implant-based reconstruction and Capsulase® supplementation in the postoperative period. These data are compared with historical data of capsular contracture in pat…
Phase: NA • Sponsor: European Institute of Oncology • Aim: Prevention
Last updated Jun 27, 2026 08:09 UTC